Navigation Links
Boehringer Ingelheim Presents New Phase II Data for Volasertib in Adult Patients with AML
Date:12/10/2012

RIDGEFIELD, Conn., Dec. 10, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today reported preliminary results from the randomized Phase II part of a Phase I/II study involving the company's investigational compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy.  In this study, higher rates of objective response (primary endpoint) and a trend for longer median event free survival (EFS) (a secondary endpoint) were observed in patients treated with volasertib in combination with low-dose cytarabine (LDAC) compared to patients treated with LDAC alone. Presented at the 54th American Society of Hematology (ASH) annual meeting in Atlanta, Ga., these results support the initiation of a Phase III study of volasertib in combination with LDAC expected to start in early 2013. 

AML is one of the most common types of leukemia in adults.2  A common treatment approach is intensive chemotherapy to induce disease remission, followed by consolidation/maintenance chemotherapy.3,4  However, many patients over 65 years of age – whose prognosis is typically poor5 – are ineligible for this approach, which involves large doses of chemotherapy over short periods of time.3,4 

The open-label study enrolled 87 adult patients randomly assigned to receive either volasertib in combination with LDAC (n=42) or LDAC alone (n=45).   The primary endpoint was objective response (complete remission [CR] or CR with incomplete blood count recovery [CRi]).  Objective responses were observed in 31 percent of patients (13 of 42 patients) treated with the combination of volasertib plus LDAC compared with 13.3 percent of the patients (6 of 45 patients) treated with LDAC alone (odds ratio: 2.91; p = 0.0523).  The median (range) time to remission was 71 (2
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Boehringer Ingelheim Announces Equine Research Awards
2. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
3. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
4. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
5. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
8. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
9. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
10. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
11. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... , April 24, 2015  Bayer Corporation hosted its annual ... at the Bayer HealthCare US headquarters.  This is Bayer,s second ... Whippany campus, and Thursday,s event welcomed ... every day at work. Fortunately, for the kids, ... a company whose mission is "Science For A Better Life," ...
(Date:4/24/2015)... , April 24, 2015 In ... establishing employee groups around the world to access ... business hours. While there are many areas to ... must examine which best practices are necessary and ... According to research by benchmarking ...
(Date:4/24/2015)... Research and Markets ( http://www.researchandmarkets.com/research/pmbmv2/global_biobanking ) ... Market 2015-2019" report to their offering. ... at a CAGR of 7.07% over the period 2014-2019 ... into two segments: Equipment and Consumables. This report covers ... Global Biobanking market for the period 2015-2019. ...
Breaking Medicine Technology:Bayer Hosts "Take Your Child to Work Day" 2Bayer Hosts "Take Your Child to Work Day" 3Bayer Hosts "Take Your Child to Work Day" 4Work Around the Clock: Building Effective Global Capabilities 2Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2
... SAN DIEGO, Jan. 6, 2012  Cardium Therapeutics (NYSE Amex: ... received notice from NYSE Regulation that the Company is ... requirements of the NYSE Amex LLC (formerly the American ... In the communication from its listing exchange, Cardium ...
... 2012 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... of Neurocrine Biosciences, will be presenting at the 30th Annual ... Hotel in San Francisco, California.    The corporate ... as outline the corporate plans for 2012 and beyond. ...
Cached Medicine Technology:Cardium Regains Listing Compliance With NYSE Amex 2Cardium Regains Listing Compliance With NYSE Amex 3Cardium Regains Listing Compliance With NYSE Amex 4Neurocrine Biosciences to Present at the 30th Annual J.P. Morgan Healthcare Conference 2
(Date:4/25/2015)... D.C. (PRWEB) April 25, 2015 The ... Bangladesh Worker Safety issues the following statement following the ... earthquake hit Kathmandu, Nepal, resulting in the deaths of ... massive earthquake were felt across Nepal, Bangladesh, India and ... offer my heartfelt condolences to the people of Nepal ...
(Date:4/25/2015)... Carinsurancequotesinfo.com has released a new blog ... auto insurance for flatbed trucks. , Flatbed ... other vehicles. They are mainly used for commercial purposes ... blog post explains that by comparing multiple offers, drivers ... other commercial vehicles. , It is now possible to ...
(Date:4/25/2015)... Caicos Islands, BWI (PRWEB) April 25, 2015 ... (PLS) has celebrated three months of successfully welcoming visitors ... January 5, 2015. , As part of a ... of Providenciales airport was completely redesigned to speed up ... up the process of getting out of the airport ...
(Date:4/25/2015)... 2015 The URO CENTER of NEW YORK ... chosen by the New York Academy of Medicine to receive ... the field of Urology. , Dr. Ferdinand Valentine, born in ... diseases. He was a man of rare and attractive ... Not only did he devote his life to his ...
(Date:4/25/2015)... April 25, 2015 For thirteen years, the ... income protection education event in the nation! This year, on ... Plus Group, US to take DI Day on the road ... G. Davidson, CLU, ChFC, RHU, DIA, CLTC, Chief Executive Officer ... Day reflects on the change by stating, "The first Twin ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes for Flatbed Trucks Available Online! 2Health News:The Tuscany on Grace Bay Celebrates Providenciales Airport Expansion With Summer Specials to Travelers! 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 3Health News:Secura Consultants Takes DI Day On The Road 2
... to reassure people that chicken is safe to eat, U.S. ... that they are free from hazardous forms of avian influenza//. ... farm before the birds are moved to processing plants, under ... trade group. Companies that account for more than 90 percent ...
... as well! The Cell Boom, a boon to communication has ... study.// ,As part of the study, ... for over 2 years. The study revealed a definite decline ... invaded work and home life. The negative impact was perceived ...
... fellow at the Women's and Children's Hospital in Adelaide, Australia ... at birth lead to severe damage of the brain tissue ... conducted in which 443 babies suffering from cerebral palsy were ... very shocking as most of the babies with cerebral palsy ...
... Gujarat Government seeks to bring down infant and mortality rates ... as 5,000 // mothers and 72,000 babies die every ... this new program named Chiranjeevi, the government aims to bring ... one. Similarly, the Health Department expects the infant mortality rate ...
... (CPI-M) and yoga guru Ramdev clashed violently on 5 January ... reported to have raised slogans against the CPI-M MP Brinda ... were laced with animal and human body parts. The police ... forcibly enter the office of the party. ...
... a rare feat, cardio-thoracic surgeons at the Government General ... in a 30-year old woman under 'spinal epidural anesthesia’. ... under general anesthesia. ,This new surgical innovation ... the patient remains conscious during the entire surgery. The ...
Cached Medicine News:Health News:U.S. Chicken Producers to Test Flocks for Bird Flu 2
... This Sarmiento style Patella-Tendon-Bearing brace is designed ... the tibia and fibula. The tibial crest ... intra medullary nailing and removal of internal ... movement of joints above and below the ...
Designed as an excellent form of primary suspension...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... This lightweight orthosis is designed to ... joint while allowing unobstructed motion of ... more custom fit the splint may ... formed using a heat gun. One ...
Medicine Products: